nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

07.09.2017 | editorial

Development of chemotherapeutics in oncology: is there anything new?

verfasst von: Holger Rumpold, Thomas Winder

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

In a decade where the dynamic development of targeted therapies and modulation of the immune system for treating cancer has dramatically changed and dominates the armamentarium of an oncologist, the topic the authors of this minireview series have been confronted was challenging: is there anything new in the development of classical cytostatic drugs and their indications? …

Nächster Artikel An Austrian view of the 2017 consensus for the treatment of early breast cancer

Titel: Development of chemotherapeutics in oncology: is there anything new?
verfasst von: Holger Rumpold
Thomas Winder
Publikationsdatum: 07.09.2017
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-017-0350-4

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Novel therapeutics in supportive cancer treatment

Highlights from the 2017 St. Gallen Breast Cancer Consensus

Chemotherapies and future directions in metastatic colorectal cancer

Local therapies for breast cancer

New chemotherapies in breast cancer

Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia